Ergomed Notice of AGM and Annual Report

RNS Number : 3649L

Ergomed plc

13 May 2022

 

Notice of AGM and Annual Report

Guildford, UK - 13 May 2022 : Ergomed plc (LSE: ERGO) ("Ergomed" or the "Company"), a company focused on providing specialised services to the pharmaceutical industry, announces that its Annual General Meeting ("AGM") will be held at 1 Cornhill, London, EC3V 3ND at 9:30 a.m. on Friday, 10 June 2022.

Ergomed's Annual Report and Accounts for the year ended 31 December 2021, Notice of AGM and Form of Proxy will be available on the Company's website at  www.ergomedplc.com  and are being mailed to its shareholders today.

ENDS

Enquiries :

Ergomed plc     Tel: [phone]

Dr Miroslav Reljanović (Executive Chairman) 

Richard Barfield (Chief Financial Officer) 

Keith Byrne (Senior Vice-President, Capital Markets & Strategy)

Numis    Tel: [phone]

Freddie Barnfield / Euan Brown (Nominated Adviser) 

James Black (Broker) 

Peel Hunt LLP    Tel: [phone]

James Steel / Dr Christopher Golden

Consilium Strategic Communications   Tel: [phone]

Chris Gardner / Matthew Neal   [e-mail]

Angela Gray

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO) and mission-critical regulatory compliance and consulting services under the ADAMAS brand. For further information, visit: http://ergomedplc.com .

 

END

 

 

NOAATMMTMTBBTPT